Previous studies reported elevated levels of the antimicrobial chemokine IP-10 (CXCL10) associated with neuroinflammation and cognitive impairment reported in Alzheimer’s disease and dementia [54,55,56,57]. Here, CXCL10 is linked to early-onset autosomal dominant Alzheimer disease.